Dr Sarah Best
Honorary (Senior Fellow)
Department of Medical Biology (WEHI)
58 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
PRMT1 Inhibition Targets BNC1-Dependent Proliferation in Squamous Cell Carcinoma
DOI: 10.1016/j.jid.2025.08.0432026
Journal article
An integrative spatial multi-omic workflow for unified analysis of tumor tissue
DOI: 10.1016/j.crmeth.2026.1013062026
Journal article
Patient-derived organoids and neurospheres recapitulate salient features of primary tumor heterogeneity
DOI: 10.1093/noajnl/vdaf2472025
Journal article
TIRE-seq simplifies transcriptomics via integrated RNA capture and library preparation
DOI: 10.1038/s41598-025-98282-82025
Journal article
Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial
DOI: 10.1038/s41591-025-03884-42025
Journal article
Spatial omics shed light on the tumour organisation of glioblastoma
DOI: 10.1016/j.semcdb.2024.12.0062025
Journal article
Tumor cell–derived spermidine promotes a protumorigenic immune microenvironment in glioblastoma via CD8 T cell inhibition
DOI: 10.1172/JCI177824
RECENT SCHOLARLY WORKS
2025
Conference Proceedings
P01.06.B Therapeutic Repurposing Reveals Novel Interventions for Heterogeneous Glioblastoma
DOI: 10.1093/neuonc/noaf193.0862024
Conference Proceedings
CNSC-36. REGULATION OF CELL FATE IN PAEDIATRIC HIGH-GRADE GLIOMA BY THE HOMEOBOX TRANSCRIPTION FACTOR DLX2
DOI: 10.1093/neuonc/noae165.01922024
Journal article
A PERIOPERATIVE STUDY OF SAFUSIDENIB IN PATIENTS WITH IDH1 MUTATED GLIOMA
DOI: 10.1093/neuonc/noae165.0382